Advertisement
Screener

Standard BioTools Inc. (LAB) ROI

STANDARD BIOTOOLS INC. ROI

Return on investment (ROI), also called return on invested capital, is the profit a company earns for every dollar of long-term capital from both lenders and shareholders, shown as a percentage. It is net income divided by long-term debt plus shareholder equity, and the table shows both amounts. Because debt is included in the base, ROI does not rise just because a company replaces equity with borrowing, which sets it apart from ROE. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.

  • STANDARD BIOTOOLS INC. roi for the quarter ending 2012-12-31 was -18.90%, a change of 14.62% year-over-year.
  • STANDARD BIOTOOLS INC. roi for the quarter ending 2012-09-30 was -18.39%, a change of 12.84% year-over-year.
  • STANDARD BIOTOOLS INC. roi for the quarter ending 2012-06-30 was -37.13%, a change of -9.27% year-over-year.
  • STANDARD BIOTOOLS INC. roi for the quarter ending 2011-12-31 was -33.52%.
  • STANDARD BIOTOOLS INC. roi for fiscal 2012 was -18.90%, a change of 14.62% from fiscal 2011.
  • STANDARD BIOTOOLS INC. roi for fiscal 2011 was -33.52%, a 446.00% decline from fiscal 2010.
  • STANDARD BIOTOOLS INC. roi for fiscal 2010 was 9.69%.
Available history
2010-12-31 to 2012-12-31
Data captured

Historical ROI

DateROINet income 12 monthNet income 3 monthDebt plus equity
2012-12-31-18.90%-$19.02M-$3.60M$100.66M
2012-09-30-18.39%-$18.88M-$4.15M$102.66M
2012-06-30-37.13%-$19.22M-$4.58M$51.75M
2011-12-31-33.52%-$22.47M-$3.46M$67.04M
2011-09-30-31.23%-$22.09M-$4.49M$70.74M
2011-06-30-27.86%-$20.98M-$7.19M$75.31M

Annual ROI

DateROINet income 12 monthDebt plus equity
2012-12-31-18.90%-$19.02M$100.66M
2011-12-31-33.52%-$22.47M$67.04M
2010-12-319.69%-$16.9M-$174.47M

Similar stocks

Stock NameCountryMarket CapPE Ratio
ROCKET PHARMACEUTICALS, INC. (RCKT)United States$0.296B-21.78
Vanda Pharmaceuticals Inc. (VNDA)United States$0.302B-1.35
Fulcrum Therapeutics, Inc. (FULC)United States$0.289B-3.28
Contineum Therapeutics, Inc. (CTNM)United States$0.289B-4.40
GT Biopharma, Inc. (GTBP)United States$0.309B-4.58
Perspective Therapeutics, Inc. (CATX)United States$0.284B-3.34
Upstream Bio, Inc. (UPB)United States$0.284B-2.42
ABEONA THERAPEUTICS INC. (ABEO)United States$0.312B-5.63
Sagimet Biosciences Inc. (SGMT)United States$0.279B
Prelude Therapeutics Inc (PRLD)United States$0.318B-7.01